Mark A. Wainberg

29.2k citations

588 papers · 21.3k indexed · 2 hit papers · h-index 71

Impact in

Virology top 0.01%
- HIV Research and Treatment
Infectious Diseases top 0.01%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 468
- HIV Research and Treatment 467
Infectious Diseases 417
- HIV/AIDS drug development and treatment 379
- HIV/AIDS Research and Interventions 208

Co-authors: Bluma Brenner Thibault Mésplède Maureen Oliveira Michael A. Parniak Daniela Moïsi Lawrence Kleiman Peter K. Quashie Yudong Quan
Journals: Journal of Virology (87 papers)Antimicrobial Agents and Chemotherapy (60 papers)AIDS (44 papers)Retrovirology (33 papers)Journal of Antimicrobial Chemotherapy (17 papers)
Partner nations: Canada United States France

In The Last Decade

Mark A. Wainberg

577 papers receiving 20.6k citations

Hit Papers

align trajectories log scale

High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection 2007 · 501 citations

Peers

Replace Daria J. Hazuda with:

Daria J. Hazuda United States

Daniel R. Kuritzkes United States

Linqi Zhang China

Robert F. Siliciano United States

John W. Mellors United States

Theodore C. Pierson United States

Huldrych F. Günthard Switzerland

Roger J. Pomerantz United States

Bonaventura Clotet Spain

Michael Farzan United States

Mark A. Wainberg relative to Daria J. Hazuda United States Daria J. Hazuda's profile →

Citations per field

00.5×1.5×2.1×

Daria J. Hazuda · 1×

×2.1 16k/7k

VIROL

×2.1 15k/7k

ID

×1.8 4k/2k

EPIDE

×1.2 877/758

HEPAT

×1.1 2k/2k

IMMUN

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by Mark A. Wainberg

Since Specialization

Citations

This map shows the geographic impact of Mark A. Wainberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Wainberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Wainberg more than expected).

Fields of papers citing papers by Mark A. Wainberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Wainberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Wainberg. The network helps show where Mark A. Wainberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Wainberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Wainberg Line = papers co-authored together Mark A. Wainberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antibody Responses to Human Immunodeficiency Virus Envelope from Infections with Multiple Subtypes Utilize the 1F7-Idiotypic Repertoire AIDS Research and Human Retroviruses ·Matthew S. Parsons, Jean‐Pierre Routy, Danielle Rouleau, Roger LeBlanc, Mark A. Wainberg, Cécile Tremblay, Marcel Zannou, Stephen J. Kent, Michael D. Grant, Nicole F. Bernard	2013	1
2	Biochemical Mechanism of HIV-1 Resistance to Rilpivirine Journal of Biological Chemistry ·Kamalendra Singh, Bruno Marchand, K. Devendra, Bechan Sharma, Eleftherios Michailidis, Emily Ryan, Kayla B. Matzek, Maxwell D. Leslie, Ariel N. Hagedorn, Zhe Li, Pieter R. Norden, Atsuko Hachiya, Michael A. Parniak, Hongtao Xu, Mark A. Wainberg, Stefan G. Sarafianos	2012	55
3	Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function Journal of Antimicrobial Chemotherapy ·Hongtao Xu, Maxwel C. Oliveira, Yudong Quan, Tamara Bar-Magen, Mark A. Wainberg	2010	15
4	Sequencing of Therapy to Avoid Resistance and the Need for New Antiretroviral Drugs in the Treatment of HIV Disease Infectious Disorders - Drug Targets ·Mark A. Wainberg, Jorge Martínez-Cajas	2009	2
5	Benefits of an educational program for journalists on media coverage of HIV/AIDS in developing countries Journal of the International AIDS Society ·Jorge Martínez-Cajas, Cédric Invernizzi, Michel Ntemgwa, Susan M. Schader, Mark A. Wainberg	2008	8
6	HIV transmission should be decriminalized: HIV prevention programs depend on it Retrovirology ·Mark A. Wainberg	2008	6
7	Substitutions in the Reverse Transcriptase and Protease Genes of HIV‐1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs Journal of the International AIDS Society ·Dan Turner, Bluma Brenner, Daniela Moïsi, Chen Liang, Mark A. Wainberg	2005	4
8	Résistance du VIH aux antirétroviraux : Conséquences pour les pays à faibles revenus médecine/sciences ·Florence Doualla‐Bell, Dan Turner, Hugues Loemba, Marco Petrella, Bluma Brenner, Mark A. Wainberg	2004	2
9	Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection AIDS ·Bluma Brenner, Jean‐Pierre Routy, Yudong Quan, Daniela Moïsi, Maureen Oliveira, Dan Turner, Mark A. Wainberg	2004	96
10	Time to act: global apathy towards HIV/AIDS is a crime against humanity The Lancet ·Robert S. Hogg, Pedro Cahn, Elly Katabira, J. de Lange, Samuel Nm, Michael V. O’Shaughnessy, Stefano Vella, Mark A. Wainberg, Julio Montaner	2002	28
11	Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent AIDS ·Sandra Rae, Janet Raboud, Brian Conway, Peter Reiss, Stefano Vella, David A. Cooper, Joep M. A. Lange, Marianne Harris, Mark A. Wainberg, Patrick Robinson, Maureen Myers, David B. Hall, Julio Montaner	1998	5
12	Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages. PubMed ·Lucia Conti, John Hiscott, Maddalena Papacchini, Anne Roulston, Mark A. Wainberg, Filippo Belardelli, Sandra Gessani	1997	24
13	Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Early Events in Reverse Transcription Advances in virus research ·Eric J. Arts, Mark A. Wainberg	1996	56
14	Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1 Archives of Virology ·Qing Gao, Zhengxian Gu, Horacio Salomón, Koutatsu Nagai, Michael A. Parniak, Mark A. Wainberg	1994	18
15	Direct involvement of extracellular HIV-1 virions in the apoptosis of CD8+ lymphocytes: A two-step model Medical Hypotheses ·L Mercure, Mark A. Wainberg	1994	5
16	Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial AIDS ·Julio Montaner, Joel Singer, Martin T. Schechter, Janet Raboud, Chris Tsoukas, Michael V. O’Shaughnessy, John Ruedy, Kazushige Nagai, Horacio Salomón, Bonnie Spira, Mark A. Wainberg	1993	62
17	Strategies in the Treatment of AIDS and Related Diseases: The Lessons of Cancer Chemotherapy Cancer Investigation ·Mark A. Wainberg, Richard G. Margolese	1992	3
18	New cd4( +) cell line susceptible to infection by hiv‐1 Journal of Medical Virology ·Michel L. Tremblay, Ronald Rooke, Romas Geleziunas, Mark A. Wainberg, Arthur K. Sullivan, Christos Tsoukas, Norbert Gilmore, Gene Shematek	1989	16
19	Expression of avian sarcoma virus genes in tumor cells derived from different periods of tumor growth Microbial Pathogenesis ·Louise Poulin, Mark A. Wainberg	1987	2
20	Mechanisms of virus-induced immune suppression. PubMed Central ·Mark A. Wainberg, Elaine L. Mills	1985	29

About Mark A. Wainberg

Mark A. Wainberg is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Hepatology, having authored 588 papers that have together received 21.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (467 papers), HIV/AIDS drug development and treatment (379 papers), HIV/AIDS Research and Interventions (208 papers), Biochemical and Molecular Research (56 papers), Immune Cell Function and Interaction (50 papers), Cytomegalovirus and herpesvirus research (33 papers), Pneumocystis jirovecii pneumonia detection and treatment (31 papers) and Virus-based gene therapy research (28 papers). The work is most often cited by research in Virology (15.5k citations), Infectious Diseases (14.7k citations), Epidemiology (4.0k citations), Hepatology (877 citations) and Immunology (2.3k citations). Mark A. Wainberg has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Bluma Brenner, Thibault Mésplède, Maureen Oliveira, Michael A. Parniak, Daniela Moïsi, Lawrence Kleiman, Peter K. Quashie, Yudong Quan, Ying-Shan Han and Chen Liang. Their work appears in journals such as Journal of Virology, Antimicrobial Agents and Chemotherapy, AIDS, Retrovirology and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact